ATLANTA, Nov. 2, 2011 /PRNewswire-USNewswire/ -- Biopharmaceutical industry insiders know that news about the world's most innovative drugs in development has always come from BioWorld. BioWorld's award-winning coverage of the biopharma industry continues, but now it's bigger, better and has more with a brand new website (www.bioworld.com).
It's easier than ever to access BioWorld Today, BioWorld Insight and BioWorld International. A brand new turbo-charged search engine facilitates more precise searches for a database that's rich with more than two decades of data on drugs in development, the companies behind those drugs, key scientific milestones, the deals, regulatory hurdles, financings and analysis.
"We've spent a lot of time and resources internally working on the site. But our focus has always been to the outside – on enhancing our content and the overall experience for our customers," said Donald R. Johnston, BioWorld's senior vice president and group publisher. "We hope both subscribers and first-time visitors spend some time exploring all of the new site's assets. We look forward to your feedback!"
Other enhancements include:
Biotech news junkies have a reason to make BioWorld.com their home page. Visit in the morning to get a daily biopharmaceutical news fix. Then stay for breaking news as it happens plus analysis, opinion and so much more.
Though anyone can tour the site now, non-subscribers have limited access to content. BioWorld is planning a free, open-access day in the very near future. Follow #bioworldfreeday to find out when.
BioWorld Today (www.bioworld.com) delivers actionable intelligence on the biotech science that drives the business, which funds the means to heal disease. With writers and editors stationed around the globe, BioWorld Today reports the breaking news and provides key perspective on hundreds of medicines in development, the companies behind those therapeutic candidates, the business development transactions that evolve the market, and the regulatory hurdles that both challenge and guard the process.
Copyright©2010 PR Newswire.
All rights reserved